The Mechanism and Clinical Research Progress of Tcm Treatment of Breast Cancer

Abstract

Breast cancer, a prevalent malignant tumor, exhibits intricate pathogenesis and rapid disease advancement. Recent analyses of both national and global scientific literature reveal the efficacy of traditional Chinese medicine (TCM) monomers or formulations in modulating biological processes. These interventions target genes and signaling pathways, leading to the inhibition of breast cancer cell proliferation, induction of apoptosis, and modulation of cancer cell resistance to chemotherapy and endocrine therapy. Moreover, emerging clinical investigations indicate the effectiveness of TCM formulations, acupuncture in conjunction with TCM, or integrative TCM and Western medicine regimens in treating breast cancer patients. These findings not only offer preliminary evidence of TCM’s potential efficacy and benefits in improving treatment outcomes and reducing toxicity in tumor diseases but also address existing limitations in Western medicine approaches to breast cancer treatment. Consequently, it is advisable to collaboratively establish a distinctive diagnostic and therapeutic framework that integrates TCM and Western medicine. Such an approach aims to diminish recurrence and mortality rates among breast cancer patients, enhance patient survival outcomes, and facilitate pertinent clinical endeavors.